Home/Federal Circuit/Glaxo Wellcome Inc. v. Genentech, Inc.

Glaxo Wellcome Inc. v. Genentech, Inc.

46 F. App'x 964
Court of Appeals for the Federal Circuit·Decided September 13, 2002·No. No. 01-1386·Published

Opinion

ORDER

GLAXO WELLCOME INC. files a stipulation and motion to dismiss the appeal pursuant to Federal Rule of Appellate Procedure 42(b).

The parties having so agreed, it is

ORDERED that the motion is granted and the proceeding is DISMISSED with prejudice under Federal Rule of Appellate Procedure 42(b). Each party to bear its own fees and costs.

Free access — add to your briefcase to read the full text and ask questions with AI

Glaxo Wellcome Inc. v. Genentech, Inc., 46 F. App'x 964 (Fed. Cir. 2002).

46 F. App'x 964 (Glaxo Wellcome Inc. v. Genentech, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.